Human and animal models demonstrate dichotomous effects of IGF-1 on the pathogenesis of AD, with both exacerbating and protective activity; therefore, further investigations are needed to better understand the multiple roles of IGF-1 and its signaling in the context of AD. Here, IGF1 is linked to Alzheimer disease.